Tenax CEO Giordano reports 4.32% ownership
Christopher Thomas Giordano, President and Chief Executive Officer of Tenax Therapeutics, reports beneficial ownership of 1,690,606 shares of common stock, representing 4.32% of the class.
Rhea-AI Filing Summary
Christopher Thomas Giordano, President and Chief Executive Officer of Tenax Therapeutics, reports beneficial ownership of 1,690,606 shares of common stock, representing 4.32% of the class. This consists of 11,324 shares of common stock and 1,679,282 shares underlying stock options.
He holds sole voting and dispositive power over these shares. The percentage is based on 37,423,917 shares of common stock outstanding as of July 28, 2026. The amendment is filed solely as a result of an increase in the number of issued and outstanding shares and is described as the final amendment and an exit filing for the reporting person.
Positive
- None.
Negative
- None.
Key Figures
Beneficially owned shares: 1,690,606 shares
Ownership percentage: 4.32 %
Shares outstanding: 37,423,917 shares
+4 more
7 metrics
Beneficially owned shares
1,690,606 shares
Tenax Therapeutics common stock beneficially owned by Christopher Thomas Giordano
Ownership percentage
4.32 %
Percent of Tenax common stock represented by Giordano’s beneficial ownership
Shares outstanding
37,423,917 shares
Tenax common shares outstanding as of July 28, 2026, from Form 10-Q
Common stock held directly
11,324 shares
Shares of Tenax common stock directly owned by Giordano
Shares underlying options
1,679,282 shares
Tenax common shares underlying stock options held by Giordano
Options at $5.94
1,241,500 shares at $5.94 per share
Stock options exercisable into Tenax common stock at $5.94
Options at $5.89
437,500 shares at $5.89 per share
Stock options exercisable into Tenax common stock at $5.89
Key Terms
beneficial ownership, stock options, sole voting power, dispositive power, +1 more
5 terms
beneficial ownership financial
"is deemed to own in the aggregate and on a beneficial ownership basis"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
stock options financial
"1,679,282 shares of Common Stock underlying stock options comprised of"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
sole voting power financial
"Number of Shares Beneficially Owned ... Sole Voting Power 1,690,606.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
dispositive power financial
"Sole Dispositive Power 1,690,606.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
exit filing regulatory
"represents the final amendment to this and constitutes an exit filing"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Tenax Therapeutics (TENX) does Christopher Thomas Giordano report?
Christopher Thomas Giordano reports beneficial ownership of 1,690,606 Tenax Therapeutics common shares, equal to 4.32% of the class. This total includes 11,324 shares of common stock and 1,679,282 shares underlying stock options.
How is Christopher Thomas Giordano’s 4.32% Tenax (TENX) ownership percentage calculated?
The 4.32% ownership is calculated using 37,423,917 Tenax common shares outstanding as of July 28, 2026. That share count is cited from the company’s Form 10-Q filed on July 31, 2026 and applied on a beneficial ownership basis.
What Tenax (TENX) stock options does Christopher Thomas Giordano hold?
Giordano is deemed to hold 1,679,282 Tenax common shares underlying stock options. These include 1,241,500 shares at $5.94, 437,500 shares at $5.89, 125 shares at $992, and 157 shares at $3,152 per share.
Why is this Tenax (TENX) Schedule 13D amendment described as an exit filing for Giordano?
The amendment states it is the final amendment and constitutes an exit filing for Giordano. It is filed solely because of an increase in issued and outstanding Tenax shares, which reduced his beneficial ownership percentage below 5%.
AI-generated analysis. How Rhea-AI works. Not financial advice.
